CHICAGO — Two bone turnover markers were significantly lower at 3 months and 1 year in postmenopausal women who received estetrol (E4) compared with patients who received placebo, according to a study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback